CRISPR-CAS9 in medicine, the saga continues

被引：0
|
作者：
Becu-Villalobos, Damasia [1 ]
机构：
[1] Consejo Nacl Invest Cient & Tecn, IBYME, Buenos Aires, DF, Argentina
来源：
MEDICINA-BUENOS AIRES | 2019年 / 79卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：522 / 523
页数：2
相关论文
共 50 条
  • [21] CRISPR-cas9: a powerful tool towards precision medicine in cancer treatment
    Hui Xing
    Ling-hua Meng
    [J]. Acta Pharmacologica Sinica, 2020, 41 : 583 - 587
  • [22] CRISPR-Cas9 technology: A new direction for personalized medicine in respiratory disease?
    Vaughan, Annalicia
    Yang, Ian A.
    [J]. RESPIROLOGY, 2019, 24 (07) : 614 - 615
  • [23] Precision medicine in the era of CRISPR-Cas9: evidence from Bosnia and Herzegovina
    Sabina Semiz
    Philip C. Aka
    [J]. Palgrave Communications, 5
  • [24] Translating genomic insights into cardiovascular medicine: Opportunities and challenges of CRISPR-Cas9
    Zhang, Yuan
    Karakikes, Ioannis
    [J]. TRENDS IN CARDIOVASCULAR MEDICINE, 2021, 31 (06) : 341 - 348
  • [25] Precision medicine in the era of CRISPR-Cas9: evidence from Bosnia and Herzegovina
    Semiz, Sabina
    Aka, Philip C.
    [J]. PALGRAVE COMMUNICATIONS, 2019, 5 (1)
  • [26] CRISPR-Cas9 strikes out in cassava
    Rybicki, Edward P.
    [J]. NATURE BIOTECHNOLOGY, 2019, 37 (07) : 727 - 728
  • [27] Advances in therapeutic application of CRISPR-Cas9
    Sun, Jinyu
    Wang, Jianchu
    Zheng, Donghui
    Hu, Xiaorong
    [J]. BRIEFINGS IN FUNCTIONAL GENOMICS, 2020, 19 (03) : 164 - 174
  • [28] Secondary Conformational Checkpoint in CRISPR-Cas9
    Zhao, Shuxin
    Liu, Jin
    Zuo, Zhicheng
    [J]. JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2024, 20 (09) : 3440 - 3448
  • [29] Chemistry Nobel Honors CRISPR-Cas9
    You Li-Lan
    Sun Wei
    Yang Xiao-Qi
    Wang Yan-Li
    [J]. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2020, 47 (11) : 1119 - 1126
  • [30] Who owns CRISPR-Cas9 in Europe?
    András Kupecz
    [J]. Nature Biotechnology, 2014, 32 : 1194 - 1196
12345